Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peptogen
Itapira, São Paulo, Brazilpeptogen.com.br ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Peptogen is a Brazilian biotechnology company specializing in the development and production of recombinant peptides and proteins for the pharmaceutical industry. Founded in 2005 and later acquired by the Cristália Group, the company operates a state-of-the-art facility dedicated to high-complexity biological synthesis. Its portfolio includes active pharmaceutical ingredients (APIs) such as somatropin, glucagon, and teriparatide. Peptogen plays a critical role in Brazil's biopharmaceutical landscape by reducing dependence on imported biological raw materials. The company focuses on scaling up laboratory processes to industrial production while maintaining strict GMP standards.
- Therapeutic areas
- Endocrinology
- Modalities
- Recombinant proteinPeptides
- Industry
- Biotech
02
Partnerships
CristáliaBNDES
Beyond the preview
Go deeper on Peptogen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peptogen.